Current diagnostic tools, such as chest radiographs and sputum cytology, lack sensitivity for the early detection of non-small cell lung cancer (NSCLC), and tumor markers like CEA, CYFRA 21–1, NSE, and SCCA are not effective for early-stage diagnosis [3]. Here, ENO2 is linked to non-small cell lung carcinoma.